TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Can Tarsus Pharmaceuticals Stock Still Offer Value After Its 48% 2025 Rally? [Yahoo! Finance]
Tarsus to Participate in Upcoming Investor Conference
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 [Seeking Alpha]
Tarsus Pharmaceuticals (NASDAQ:TARS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $100.00 price target on the stock.
Tarsus Pharmaceuticals (NASDAQ:TARS) was upgraded by analysts at Wall St
Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: Deep Track Capital, LP
Form 10-Q Tarsus Pharmaceuticals, For: Sep 30
Form 8-K Tarsus Pharmaceuticals, For: Nov 04
Form 4 Tarsus Pharmaceuticals, For: Sep 24 Filed by: Azamian Bobak R.
Form 144 Tarsus Pharmaceuticals, Filed by: Azamian Bobak R.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.